Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis

Tumor angiogenesis plays a crucial role in tumor growth, progression and metastasis, and suppression of tumor angiogenesis has been considered as a promising anticancer strategy. Salinomycin (SAL), an antibiotic, displays novel anticancer potential against several human cancer cells in vitro and in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Mol Med
Päätekijät: Bi, Yan-Ling, Mi, Pei-Yan, Zhao, Shi-Jun, Pan, Heng-Ming, Li, Hui-Juan, Liu, Fei, Shao, Lu-Rong, Zhang, Hui-Fang, Zhang, Pu, Jiang, Shi-Liang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2017
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403467/
https://ncbi.nlm.nih.gov/pubmed/28358414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2017.2940
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia